Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
SNES 
SenesTech Inc (SNES)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: SNES (1-star) is a SELL. SELL since 5 days. Profits (83.92%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $10
1 Year Target Price $10
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 51.59% | Avg. Invested days 58 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 24.08M USD | Price to earnings Ratio - | 1Y Target Price 10 |
Price to earnings Ratio - | 1Y Target Price 10 | ||
Volume (30-day avg) 1 | Beta 0.21 | 52 Weeks Range 1.30 - 6.24 | Updated Date 08/15/2025 |
52 Weeks Range 1.30 - 6.24 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.3 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date 2025-08-07 | When - | Estimate - | Actual -0.87 |
Profitability
Profit Margin -289.01% | Operating Margin (TTM) -258.24% |
Management Effectiveness
Return on Assets (TTM) -52.78% | Return on Equity (TTM) -119.89% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 20712099 | Price to Sales(TTM) 11.5 |
Enterprise Value 20712099 | Price to Sales(TTM) 11.5 | ||
Enterprise Value to Revenue 9.9 | Enterprise Value to EBITDA 0.11 | Shares Outstanding 5223020 | Shares Floating 5132343 |
Shares Outstanding 5223020 | Shares Floating 5132343 | ||
Percent Insiders 1.74 | Percent Institutions 1.52 |
Upturn AI SWOT
SenesTech Inc
Company Overview
History and Background
SenesTech, Inc. was founded in 2004 and is headquartered in Flagstaff, Arizona. It focuses on developing and commercializing non-lethal methods of managing animal pest populations through fertility control.
Core Business Areas
- Fertility Control: Develops and commercializes products for managing animal pest populations through fertility control, focusing primarily on rat populations.
Leadership and Structure
The leadership team typically includes a CEO, CFO, and other key executives. The organizational structure is a standard corporate hierarchy.
Top Products and Market Share
Key Offerings
- ContraPest: ContraPest is SenesTech's primary product, a liquid bait that induces infertility in both male and female rats. Market share data is limited, but SenesTech targets large urban areas and agricultural settings. Competitors include traditional rodenticides (e.g., JT Eaton, Bell Laboratories) and integrated pest management solutions.
Market Dynamics
Industry Overview
The pest control industry is a mature market, with increasing demand for environmentally friendly and humane solutions. Rodent control represents a significant portion of the overall market.
Positioning
SenesTech positions itself as an eco-friendly alternative to traditional rodenticides, targeting customers concerned about environmental impact and secondary poisoning. Its competitive advantage lies in its novel approach to fertility control.
Total Addressable Market (TAM)
The estimated global rodent control market is worth billions of dollars annually. SenesTech is trying to penetrate the pest control market which according to Orbis Research is around $30 billion. SenesTech is positioned to capture a small, but growing, share of this market by offering a nontoxic alternative.
Upturn SWOT Analysis
Strengths
- Unique product offering (fertility control)
- Environmentally friendly alternative to rodenticides
- Addresses growing demand for humane pest control
Weaknesses
- Limited market share
- Dependence on a single product (ContraPest)
- Regulatory hurdles and approvals
- Cash Flow negative, needing to raise capital
Opportunities
- Expansion into new geographic markets
- Development of new fertility control products for other pests
- Partnerships with pest control companies
- Increased regulatory support for non-lethal methods
Threats
- Competition from established pest control companies
- Resistance to ContraPest
- Changes in regulations regarding pest control methods
- Economic downturn impacting pest control spending
Competitors and Market Share
Key Competitors
- VRNC
- BASF
- SYNGY
Competitive Landscape
SenesTech faces intense competition from established pest control companies with broader product portfolios and larger distribution networks. Its advantage lies in its unique product and environmentally friendly approach. However, widespread acceptance is challenging given current market share and limited finances.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been slow, with limited product adoption.
Future Projections: Analysts expect revenue growth in the coming years, but profitability remains uncertain.
Recent Initiatives: Recent initiatives include expanding sales and marketing efforts and pursuing regulatory approvals in new markets.
Summary
SenesTech is a company pioneering a unique approach to pest control, but currently it struggles with profitability and significant losses. Its innovative fertility control product, ContraPest, has the potential to disrupt the pest control industry. Its small market share and negative cash flow requires SenesTech to be agile. The company needs to be very cautious in its strategic implementation of revenue streams.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Market Research Reports
- Analyst Estimates
Disclaimers:
This analysis is based on publicly available information and analyst estimates. It is not financial advice. Investment decisions should be based on thorough research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SenesTech Inc
Exchange NASDAQ | Headquaters Phoenix, AZ, United States | ||
IPO Launch date 2016-12-08 | CEO, President & Director Mr. Joel L. Fruendt | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 23 | Website https://www.senestech.com |
Full time employees 23 | Website https://www.senestech.com | ||
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice after one to two breeding cycles following consumption. The company also provides teleconsulting and technical advisory services. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.